YH005

YH005 is an anti-Claudin 18.2 antibody generated using our Claudin 18.2 knock-out mice. We have out-licensed YH005 to RemeGen for the development RC118, a potentially first-in-class ADC for the treatment of solid tumors. RC118 is currently at IND stage in China and Australia.

Back to top